Utilization of Empagliflozin in Patients with Type 2 Diabetes Mellitus and Congestive Heart Failure

被引：0
|
作者：
Alvarez, Carlos A.
Perkins, Aaron
Sigler, Meredith A.
Yang, Hui
Caberwal, Harjeet
Ebrahimi, Ramin
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-872-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
872-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prevalance of Congestive Heart Failure Aniong Patients With Type 2 Diabetes Mellitus
    Ataoglu, Meral
    Karaali, Zeynep
    Poturoglu, Sule
    Aktuglu, Mehmet Burak
    Saglam, Zuhal
    Alioglu, Taner
    Kendir, Mehmet
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2009, 47 (03): : 122 - 128
  • [2] Diabetes mellitus and congestive heart failure: the prevalence of congestive heart failure in patients with and without diabetes in Poland
    Wierzba, Waldemar
    Karnafel, Waldemar
    Sliwczynski, Andrzej
    Pinkas, Jaroslaw
    Gujski, Mariusz
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (03) : 646 - 651
  • [3] Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus
    Filion, Kristian B.
    Joseph, Lawrence
    Boivin, Jean-Francois
    Suissa, Samy
    Brophy, James M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (08) : 785 - 796
  • [4] IMPACT OF EMPAGLIFLOZIN IN REDUCING HOSPITALIZATION RATES IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC HEART FAILURE
    Yagudina, R.
    Kulikov, A.
    Serpik, V
    Protsenko, M.
    Kopeyka, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S350 - S350
  • [5] Diabetes Mellitus and Congestive Heart Failure
    Odawara, Masato
    [J]. JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S139 - S139
  • [6] Heart failure in patients with type 2 diabetes mellitus
    Vlad, Adrian
    Serban, Viorel
    Timar, Romulus
    Darabantiu, Dan
    [J]. DIABETES, 2007, 56 : A588 - A588
  • [7] PREDICTORS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH EMPAGLIFLOZIN
    Lebedev, Denis
    Lyasnikova, Elena
    Vasilyeva, Elena
    Sitnikova, Maria
    Babenko, Alina
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E190 - E190
  • [8] PREDICTORS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH EMPAGLIFLOZIN
    Lebedev, Denis
    Lyasnikova, Elena
    Vasilyeva, Elena
    Sitnikova, Maria
    Babenko, Alina
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E190 - E190
  • [9] Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure
    Elrakaybi, A.
    Laubner, K.
    Zhou, Q.
    Paeth, G.
    Schmitt, H.
    Hug, M. J.
    Seufert, J.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S24 - S24
  • [10] Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure
    Granberry, Mark C.
    Hawkins, Jason B.
    Franks, Amy M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (09) : 931 - 936
12345